Abstract:
The
first vaccines against SARS-CoV-2 have now received
emergency use authorization by the U.S. Food and Drug
Administration (FDA), European Medicines Agency (EMA) and
national authorities in China, India, UK, and Russia; and are rapidly
being distributed in more than 30 countries since the end of the
2020. So far vaccines are being used by the respective countries
after national approval based on promising efficacy reports and
safety data, however, data on some of these vaccines have not yet
been published in international peer-reviewed journals. The World
Health Organization (WHO) has a role in “pre-qualifying” COVID
vaccines, but WHO pre-qualification may not be necessary to
record the use of immunization or prophylaxis in WHO Interna-
tional Certificate of Vaccination or Prophylaxis (ICVP, aka Carte
Jaune or Yellow Card) as this has not been the case with other
vaccines which may not be WHO prequalified. Every dose of any
COVID vaccine should be entered in the WHO Yellow Card.
